...
首页> 外文期刊>PLoS Genetics >A Genome-Wide Association Study Reveals Variants in ARL15 that Influence Adiponectin Levels
【24h】

A Genome-Wide Association Study Reveals Variants in ARL15 that Influence Adiponectin Levels

机译:全基因组关联研究揭示了影响脂联素水平的ARL15变异。

获取原文
           

摘要

The adipocyte-derived protein adiponectin is highly heritable and inversely associated with risk of type 2 diabetes mellitus (T2D) and coronary heart disease (CHD). We meta-analyzed 3 genome-wide association studies for circulating adiponectin levels (n?=?8,531) and sought validation of the lead single nucleotide polymorphisms (SNPs) in 5 additional cohorts (n?=?6,202). Five SNPs were genome-wide significant in their relationship with adiponectin (P≤5×10?8). We then tested whether these 5 SNPs were associated with risk of T2D and CHD using a Bonferroni-corrected threshold of P≤0.011 to declare statistical significance for these disease associations. SNPs at the adiponectin-encoding ADIPOQ locus demonstrated the strongest associations with adiponectin levels (P-combined?=?9.2×10?19 for lead SNP, rs266717, n?=?14,733). A novel variant in the ARL15 (ADP-ribosylation factor-like 15) gene was associated with lower circulating levels of adiponectin (rs4311394-G, P-combined?=?2.9×10?8, n?=?14,733). This same risk allele at ARL15 was also associated with a higher risk of CHD (odds ratio [OR]?=?1.12, P?=?8.5×10?6, n?=?22,421) more nominally, an increased risk of T2D (OR?=?1.11, P?=?3.2×10?3, n?=?10,128), and several metabolic traits. Expression studies in humans indicated that ARL15 is well-expressed in skeletal muscle. These findings identify a novel protein, ARL15, which influences circulating adiponectin levels and may impact upon CHD risk.
机译:脂肪细胞衍生的脂联素是高度可遗传的,并且与2型糖尿病(T2D)和冠心病(CHD)的风险成反比。我们对循环脂联素水平(n == 8,531)进行了3个全基因组关联研究的荟萃分析,并试图在另外5个队列(n == 6202)中验证先导单核苷酸多态性(SNP)。 5个SNP与脂联素的关系在全基因组中具有显着性(P≤5×10?8)。然后,我们使用Bonferroni校正的P≤0.011阈值测试了这5个SNP是否与T2D和CHD风险相关,以声明这些疾病相关的统计学意义。编码脂连蛋白的ADIPOQ基因座处的SNP显示出与脂连蛋白水平的最强关联(铅SNP的P-组合β=≥9.2×10≤19,rs266717,nα=≥14,733)。 ARL15(ADP-核糖基化因子样15)基因中的新变体与脂联素的较低循环水平有关(rs4311394-G,P-结合的α=β2.9×10β8,nα=α14,733)。在ARL15处,相同风险等位基因还与冠心病的更高风险相关(奇数比[OR]?=?1.12,P?=?8.5×10?6,n?=?22,421),T2D的风险增加。 (OR == 1.11,P == 3.2×10 = 3,n == 10,128),以及一些代谢性状。在人中的表达研究表明,ARL15在骨骼肌中表达良好。这些发现确定了一种新型蛋白质ARL15,该蛋白质会影响循环脂联素水平并可能影响冠心病风险。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号